Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Neuroreport|December 24, 2008
Interaction between PON1 and population density in amyotrophic lateral sclerosisFrank P Diekstra, Ana Beleza-Meireles, Nigel P Leigh, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 27, 2014
Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndromeElisabeth A Cats, W-Ludo van der Pol, Anne P Tio-Gillen, et al.Neurobiology of Aging|April 18, 2012
CGG-repeat expansion in FMR1 is not associated with amyotrophic lateral sclerosisEwout J N Groen, Wouter van Rheenen, Max Koppers, et al.Plos One|June 26, 2018
Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker studyWouter van Rheenen, Frank P Diekstra, Oliver Harschnitz, et al.Neurobiology of Aging|November 29, 2011
UNC13A is a modifier of survival in amyotrophic lateral sclerosisFrank P Diekstra, Paul W J van Vught, Wouter van Rheenen, et al.Scientific Reports|April 13, 2019
Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosisAnnelot M Dekker, Frank P Diekstra, Sara L Pulit, et al.Neurology|October 6, 2017
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trialsRuben P A van Eijk, Ashley R Jones, William Sproviero, et al.Neurobiology of Aging|October 16, 2012
H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosisWouter van Rheenen, Frank P Diekstra, Perry T C van Doormaal, et al.Plos One|April 18, 2012
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALSFrank P Diekstra, Christiaan G J Saris, Wouter van Rheenen, et al.Human Mutation|July 18, 2017
The role of de novo mutations in the development of amyotrophic lateral sclerosisPerry T C van Doormaal, Nicola Ticozzi, Jochen H Weishaupt, et al.Pageof 2